GPATCH3 and glaucoma: All variants identified in glaucoma patients, except c.111 + 74A > T, were bioinformatically predicted to dysregulate GPATCH3 function not only at the protein level but also at the level of transcription or translation, affecting the dosage of the gene product, suggesting that they are disease-causing-variants.